Abstract
Cytomegalovirus (CMV) gastrointestinal (GI) disease has been noticed frequently in cancer patients, causing abdominal pain, diarrhea, and GI bleeding. However, little is known about its actual incidence, clinical presentation, and the risk factors for its development among cancer patients. To answer these questions, we analyzed all cases that occurred during an 18-year period at our center. A case–control study was performed to identify risk factors for CMV GI disease. Electronic medical records were reviewed from individuals who were admitted and diagnosed with CMV GI disease during the period of January 1995 through March 2013 at a tertiary care center. Two CMV disease-free cancer patients were matched as controls. A total of 98 episodes of CMV GI disease were included in this study, and the overall incidence rate was 52.5 per 100,000 cancer patients, with an increasing trend throughout the study period. According to multivariate analysis, male sex, low body mass index, lymphopenia, hematological malignancy, and steroid use and red blood cell transfusion within 1 month prior to the CMV disease were identified to be independent risk factors. Among these factors, RBC transfusion showed the highest odds ratio (OR = 5.09). Male sex, low body mass index, lymphopenia, hematological malignancy, steroid use, and red blood cell transfusion within 1 month prior to the CMV disease diagnosis were independent risk factors for the development of CMV GI disease in adult patients with cancer.
Similar content being viewed by others
References
McGavran MH, Smith MG (1965) Ultrastructural, cytochemical, and microchemical observations on cytomegalovirus (Salivary Gland Virus) infection of human cells in tissue culture. Exp Mol Pathol 76:1–10
Gandhi MK, Khanna R (2004) Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 4:725–738. doi:10.1016/S1473-3099(04)01202-2
Gandhi MK, Wills MR, Sissons JG, Carmichael AJ (2003) Human cytomegalovirus-specific immunity following haemopoietic stem cell transplantation. Blood Rev 17:259–264
Cope AV, Sweny P, Sabin C, Rees L, Griffiths PD, Emery VC (1997) Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation. J Med Virol 52:200–205
Jacobson MA (1997) Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 337:105–114. doi:10.1056/NEJM199707103370207
Saito M, Ishino A, Ito T, Sakuma T, Matsuzaki M, Katagata N, Watanabe F, Takenoshita S, Nomizu T (2013) Hemorrhagic cytomegalovirus colitis in a postoperative colon cancer patient. Case Rep Oncol 6:109–113. doi:10.1159/000348711
Nomura K, Kamitsuji Y, Kono E, Matsumoto Y, Yoshida N, Konishi H, Horiike S, Okanoue T, Taniwaki M (2005) Severe cytomegalovirus enterocolitis after standard chemotherapy for non-Hodgkin’s lymphoma. Scand J Gastroenterol 40:604–606. doi:10.1080/00365520510015395
Furukawa Y, Nakamura H, Sakamoto S, Miura Y (1988) Cytomegalovirus gastritis as an initial manifestation of a patient with adult T-cell leukemia. Acta Haematol 80:216–218
Reed EC, Wolford JL, Kopecky KJ, Lilleby KE, Dandliker PS, Todaro JL, McDonald GB, Meyers JD (1990) Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial. Ann Intern Med 112:505–510
Sohn YM, Park KI, Lee C, Han DG, Lee WY (1992) Congenital cytomegalovirus infection in Korean population with very high prevalence of maternal immunity. J Korean Med Sci 7:47–51
Seo S, Cho Y, Park J (2009) Serologic screening of pregnant Korean women for primary human cytomegalovirus infection using IgG avidity test. Korean J Lab Med 29:557–562. doi:10.3343/kjlm.2009.29.6.557
Kim JM, Kim SJ, Joh JW, Kwon CH, Shin M, Kim EY, Moon JI, Jung GO, Choi GS, Lee SK (2010) Early and delayed onset cytomegalovirus infection of liver transplant recipients in endemic areas. Transplant Proc 42:884–889. doi:10.1016/j.transproceed.2010.02.025
Kim T, Sung H, Park KT, Kim SC, Kim S-H, Choi S-H, Kim YS, Woo JH, Park S-K, Han DJ, Lee S-O (2009) Clinical usefulness of human cytomegalovirus antigenemia assay after kidney transplantation. Infect Chemother 41:72. doi:10.3947/ic.2009.41.2.72
Mori T, Mori S, Kanda Y, Yakushiji K, Mineishi S, Takaue Y, Gondo H, Harada M, Sakamaki H, Yajima T, Iwao Y, Hibi T, Okamoto S (2004) Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 33:431–434. doi:10.1038/sj.bmt.1704369
Galiatsatos P, Shrier I, Lamoureux E, Szilagyi A (2005) Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig Dis Sci 50:609–616
Kotler DP (2000) Cachexia. Ann Intern Med 133:622–634
Teo HK, Price P, Papadimitriou JM (1991) The effects of protein malnutrition on the pathogenesis of murine cytomegalovirus disease. Int J Exp Pathol 72:67–82
Yi F, Zhao J, Luckheeram RV, Lei Y, Wang C, Huang S, Song L, Wang W, Xia B (2013) The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China. Virol J 10:43. doi:10.1186/1743-422X-10-43
Chen YM, Hung YP, Huang CF, Lee NY, Chen CY, Sung JM, Chang CM, Chen PL, Lee CC, Wu YH, Lin HJ, Ko WC (2013) Cytomegalovirus disease in nonimmunocompromised, human immunodeficiency virus-negative adults with chronic kidney disease. J Microbiol Immunol Infect. doi:10.1016/j.jmii.2013.01.011
Reusser P, Attenhofer R, Hebart H, Helg C, Chapuis B, Einsele H (1997) Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants. Blood 89:3873–3879
Whitley RJ, Jacobson MA, Friedberg DN, Holland GN, Jabs DA, Dieterich DT, Hardy WD, Polis MA, Deutsch TA, Feinberg J, Spector SA, Walmsley S, Drew WL, Powderly WG, Griffiths PD, Benson CA, Kessler HA (1998) Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med 158:957–969
Lim SH, Pathapati S, Langevin J, Hoot A (2012) Severe CMV reactivation and gastritis during treatment of follicular lymphoma with bendamustine. Ann Hematol 91:643–644. doi:10.1007/s00277-011-1307-z
Yeh YM, Chen YP, Wu HC, Su WC, Chen TY (2009) Cytomegalovirus-related neutropenic enterocolitis with negative CMV antigenemia as the initial presentation in an acute myeloid leukemia patient. Ann Hematol 88:279–280. doi:10.1007/s00277-008-0596-3
Stuck AE, Minder CE, Frey FJ (1989) Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 11:954–963
Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, Kohler JA, Furst DE (1994) Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 96:115–123
Takizawa Y, Inokuma S, Tanaka Y, Saito K, Atsumi T, Hirakata M, Kameda H, Hirohata S, Kondo H, Kumagai S, Tanaka Y (2008) Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population. Rheumatology (Oxford) 47:1373–1378. doi:10.1093/rheumatology/ken231
Lee HS, Park JY, Shin SH, Kim SB, Lee JS, Lee A, Ye BJ, Kim YS (2012) Herpesviridae viral infections after chemotherapy without antiviral prophylaxis in patients with malignant lymphoma: incidence and risk factors. Am J Clin Oncol 35:146–150. doi:10.1097/COC.0b013e318209aa41
Chang H, Tang TC, Hung YS, Lin TL, Kuo MC, Wang PN (2011) Cytomegalovirus infection in non-transplant patients with hematologic neoplasms: a case series. Chang Gung Med J 34:65–74
Wadhawan M, Gupta S, Goyal N, Vasudevan KR, Makki K, Dawar R, Sardana R, Lal N, Kumar A (2012) Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience. Liver Transpl 18:1448–1455. doi:10.1002/lt.23540
Al-Hajjar S, Al Seraihi A, Al Muhsen S, Ayas M, Al Jumaah S, Al Jefri A, Shoukri M, El Solh H (2011) Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes. Hematol Oncol Stem Cell Ther 4:67–72
Lang DJ (1972) Cytomegalovirus infections in organ transplantation and post transfusion. An hypothesis. Arch Gesamte Virusforsch 37:365–377
Adler SP, Baggett J, McVoy M (1985) Transfusion-associated cytomegalovirus infections in seropositive cardiac surgery patients. Lancet 2:743–747
Funding
This work was not financially supported.
Conflict of interest
All authors: no reported conflicts.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ko, JH., Peck, K.R., Lee, W.J. et al. Risk factors for cytomegalovirus gastrointestinal diseases in adult patients with cancer. Eur J Clin Microbiol Infect Dis 33, 1847–1853 (2014). https://doi.org/10.1007/s10096-014-2107-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-014-2107-x